Multi-Specific Antibody Self-Assembly Technology
Our internationally patented technology, NAPPA™, can achieve instant and precise assembly of multiple antibody fragments that target different antigens to form multi-specific antibodies (MsAbs). This game-changing technology makes the preparation of high-order MsAbs (e.g., 3, 4, 5) as easy as the common bi-specific antibodies. The high-order MsAbs can target multiple cancer antigens while turning on multiple switches to activate immune cells.